Tasly Pharmaceutical Group Co., Ltd (SHA:600535)
China
· Delayed Price · Currency is CNY 15.27
+0.04 (0.26%)
May 13, 2025, 2:45 PM CST
SHA:600535 Revenue
Tasly Pharmaceutical Group had revenue of 2.05B CNY in the quarter ending March 31, 2025, with 0.30% growth. This brings the company's revenue in the last twelve months to 8.50B, down -1.55% year-over-year. In the year 2024, Tasly Pharmaceutical Group had annual revenue of 8.50B, down -2.03%.
Revenue (ttm)
8.50B
Revenue Growth
-1.55%
P/S Ratio
2.68
Revenue / Employee
776.09K
Employees
10,958
Market Cap
22.81B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 8.50B | -175.87M | -2.03% |
| Dec 31, 2023 | 8.67B | 36.58M | 0.42% |
| Dec 31, 2022 | 8.64B | 685.47M | 8.62% |
| Dec 31, 2021 | 7.95B | -5.62B | -41.43% |
| Dec 31, 2020 | 13.58B | -5.42B | -28.54% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 29.19B |
| Shenzhen Mindray Bio-Medical Electronics | 35.59B |
| WuXi AppTec | 39.59B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
| Aier Eye Hospital Group | 21.81B |
| Sichuan Biokin Pharmaceutical | 5.82B |
| Shanghai United Imaging Healthcare | 10.43B |
| Yunnan Baiyao Group Co.,Ltd | 40.10B |